RELOVAIR

Type: Product

Name: RELOVAIR

Quotes

...is one step closer to providing an important therapeutic option to COPD patients,” said Rick E Winningham, chief executive officer of Theravance. "We are proud to collaborate with GSK on the development and potential commercialisation of treatments for COPD and other respiratory diseases. The panel’s positive recommendation of Breo Ellipta represents an important achievement in a transformative year for Theravance.”"

US FDA committee recommends approval of Breo Ellipta to treat COPD [Published PharmaBiz - Apr 19 2013]

...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."

XTXI, XKE, HCSG, XRAY, THRX, CAP Are Seasonally Ripe To Go Up In the Next Five Weeks [Published Individual.com - Apr 18 2013]

Patrick Vallance, GSK's President of Pharmaceuticals, R&D, said: "We are pleased with the outcome of today's meeting.$ COPD is a debilitating and progressive disease. Its symptoms are often severe and can have a huge impact on patients' lives. This positive recommendation is a crucial first step towards making BREO ELLIPTA available for appropriate COPD patients across the US. We look forward to a final decision from the FDA later this year."

FDA Advisory Committee recommends approval of BREO™ ELLIPTA™ for the treatment of COPD PR Newswire [Published Yahoo! Finance - Apr 17 2013]

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/47jdbq/glaxosmith_kline) has announced the addition of the "Glaxo-Smith Kline and Theravance's Relovair: Will it be a breath of fresh air or are there regulatory hurdles ahead?" report to their offering...

Research and Markets: Glaxo-Smith Kline and Theravance's Relovair: Will it be a breath of fresh a ... [Published Business Wire Health News - Jan 04 2013]

More Content

sort by: Date \| Relevance
Market Access for nebulisers in asthma – UK pay... [Published pharmaphorum - May 01 2013]
FDA Advisory Committee Recommends Approval Of B... [Published Drug Discovery Online - May 01 2013]
US FDA committee recommends approval of Breo El... [Published PharmaBiz - Apr 19 2013]
XTXI, XKE, HCSG, XRAY, THRX, CAP Are Seasonally... [Published Individual.com - Apr 18 2013]
FDA Advisory Committee recommends approval of B... [Published Yahoo! Finance - Apr 17 2013]
GLAXOSMITHKLINE PLC: FDA Advisory Committee rec... [Published 4 Traders - Apr 17 2013]
FDA Advisory Committee Recommends Approval of B... [Published Market Wire - Apr 17 2013]
Research and Markets: Glaxo-Smith Kline and The... [Published Business Wire Health News - Jan 04 2013]